Danish drugmaker Bavarian Nordic said Friday it was seeking European approval to use its mpox vaccine in children aged 12 to 17, after the WHO declared the current virus surge a global public health emergency. The World Health Organization (WHO) this week declared the rapid spread of the new, more dangerous mpox strain, dubbed Clade […]
The post Mpox vaccine maker seeks approval for use in teens appeared first on Insider Paper.